Evidence map›Paper›PMID 38799793›Full record

ArticleBrain, behavior, & immunity - health2024

Trait-anxiety and glial-related neuroinflammation of the amygdala and its associated regions in Alzheimer's disease: A significant correlation.

Fumihiko Yasuno, Yasuyuki Kimura, Aya Ogata, Hiroshi Ikenuma, Junichiro Abe, Hiroyuki Minami, Takashi Nihashi, Kastunori Yokoi, Saori Hattori, Nobuyoshi Shimoda and 7 more

Abstract read
In one paragraph

Article in Brain, behavior, & immunity - health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Fumihiko YasunoNational Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.
Yasuyuki KimuraNational Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.
Aya OgataDepartment of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan.
Hiroshi IkenumaDepartment of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan.
Junichiro AbeDepartment of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan.
Hiroyuki MinamiNational Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.
Takashi NihashiNational Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.
Kastunori YokoiNational Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.
Saori HattoriDepartment of Clinical and Experimental Neuroimaging, Center for Development of Advanced Medicine for Dementia, National Center for Geriatrics and Gerontology, Obu, Japan.
Nobuyoshi ShimodaFunctional Genomics Unit, Medical Genome Center, National Center for Geriatrics and Gerontology, Obu, Japan.
Atsushi WatanabeEquipment Management Division, Center for Core Facility Administration, National Center for Geriatrics and Gerontology, Obu, Japan.
Kensaku KasugaDepartment of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.
Takeshi IkeuchiDepartment of Molecular Genetics, Brain Research Institute, Niigata University, Niigata, Japan.
Akinori TakedaNational Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.
Takashi SakuraiNational Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.
Kengo ItoNational Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.
Takashi KatoNational Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology, Obu, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Positron emission tomography, which assesses the binding of translocator protein radiotracers, Methods: Nineteen patients with AD continuum determined to be amyloid-/p-tau 181-positive via cerebrospinal fluid analysis were included in this cross-sectional study (mild cognitive impairment [MCI, n = 5] and AD [n = 14]). Anxiety was evaluated using the State-Trait Anxiety Inventory (STAI). A whole-brain voxel-based analysis was performed to examine the relationship between Results: Voxel-based analysis revealed a positive correlation between trait anxiety severity and Conclusions: The amygdala-occipital lobe circuit influences the control of emotional generation, and disruption of this network by AD pathology-induced inflammation may contribute to the expression of anxiety. Our findings suggest that suppression of inflammation can help effectively treat anxiety by attenuating damage to the amygdala and its associated areas.

Indexed as

Alzheimer's diseaseamygdalaAnxietyInflammationPositron emission tomography (PET)State-Trait Anxiety Inventory (STAI)

Identifiers

PMID38799793
PMCPMC11126804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.